Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
Gallardo, A, Lerma, E, Escuin, D, Tibau, A, Muñoz, J, Ojeda, B, Barnadas, A, Adrover, E, Sánchez-Tejada, L, Giner, D, Ortiz-Martínez, F, Peiró, G
Published in British journal of cancer (10.04.2012)
Published in British journal of cancer (10.04.2012)
Get full text
Journal Article
Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
Peiró, G, Ortiz-Martínez, F, Gallardo, A, Pérez-Balaguer, A, Sánchez-Payá, J, Ponce, J J, Tibau, A, López-Vilaro, L, Escuin, D, Adrover, E, Barnadas, A, Lerma, E
Published in British journal of cancer (12.08.2014)
Published in British journal of cancer (12.08.2014)
Get full text
Journal Article
Magnitude of clinical benefit of cancer drugs and time to health technology assessment (HTA) decisions in Europe
Hwang, T., Vokinger, K., Tibau, A., Gyawali, B., Naci, H., Franklin, J.M., Beall, R., Kesselheim, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial
Alba, E, Albanell, J, de la Haba, J, Barnadas, A, Calvo, L, Sánchez-Rovira, P, Ramos, M, Rojo, F, Burgués, O, Carrasco, E, Caballero, R, Porras, I, Tibau, A, Cámara, M C, Lluch, A
Published in British journal of cancer (04.03.2014)
Published in British journal of cancer (04.03.2014)
Get full text
Journal Article
Magnitude of clinical benefit of trials supporting US Food and Drug Administration (FDA) approval of breakthrough and non-breakthrough drugs
Molto Valiente, C., Borrell, M., Hwang, T., Gich Saladich, I., Barnadas, A., Amir, E., Kesselheim, A., Tibau, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Magnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approval
Borrell Puy, M., Molto Valiente, C., Vokinger, K., Hwang, T., Ocana Fernandez, A., Templeton, A.J., Seruga, B., Gich Saladich, I., Barnadas, A., Amir, E., Tibau, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Magnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA)
Molto Valiente, C., Borrell, M., Ocana Fernandez, A., Templeton, A.J., del Carpio, L.P., Del Paggio, J., Barnadas, A., Booth, C.M., Tibau, A., Amir, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Electronic health records and patient registries in medical oncology departments in Spain
Ribelles, N., Alvarez-Lopez, I., Arcusa, A., Chacon, J. I., de la Haba, J., García-Corbacho, J., Garcia-Mata, J., Jara, C., Jerez, J. M., Lázaro-Quintela, M., Leon-Mateos, L., Ramirez-Merino, N., Tibau, A., Garcia-Palomo, A.
Published in Clinical & translational oncology (01.10.2021)
Published in Clinical & translational oncology (01.10.2021)
Get full text
Journal Article
1229 Industry-Sponsored Posters at Major Oncology Conferences: Science or Marketing?
Guerra, R.B, Toloi, D, Tibau, A, Ocana, A, Seruga, B, Vera-Badillo, F, Amir, E, Tannock, I.F, Templeton, A.J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
266 Predictive and prognostic value of microtubule-associated protein-tau and classes I to IV b-tubulin isotypes in locally advancedbreast cancer
Tibau, A, López Vilar ó, L, Anguera, G, Virgili, A, Pérez-Olabarria, M, Vázquez, T, Gich, I, Alonso, C, Ojeda, B, Ramoń y Cajal, T, Murata, P, Enrique, L, Escuin, D, Barnadas, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1215 Role of cooperative groups and funding source in clinical studies that support approved therapy for breast cancer
Anguera, G, Tibau, A, Andrés-Pretel, F, Andrés, M, Seruga, B, Templeton, A.J, Jerez, Y, Vera-Badillo, F, Barnadas, A, Martin, M, Amir, E, Ocańa, A
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1703P Value of molecular targets and genome-targeted cancer therapies FDA-approved, 2015-2022
Tibau, A., Hwang, T.J., Consolacion, M., Avorn, J., Kesselheim, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1631PD_PR - Clinical benefit and prices of cancer drugs in the US and Europe
Vokinger, K.N., Hwang, T., Tibau, A., Rosemann, T.J., Kesselheim, A.S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Clinical benefit and prices of cancer drugs in the US and Europe
Vokinger, K.N., Hwang, T., Tibau, A., Rosemann, T.J., Kesselheim, A.S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1704P Clinical benefit of cancer drugs approved by the US food and drug administration based on appropriateness of control arm and its change over time
Molto, C., Restrepo, A.P., Templeton, A.J., Tibau, A., Mittal, A., Tamimi, F.T., Malon Gimenez, D., Amir, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1938P Assessment of clinical benefit of cancer drugs recommended in National Comprehensive Cancer Network (NCCN) guidelines for advanced soft tissue sarcomas (STS) and bone sarcomas (BS)
Sorolla, M. Aguado, Lleida, R. Teres, Piedra, A., Cardozo, A.R., Bosma, F., Serda, P. Cerda, Pousa, A. Lopez, Tibau, A., Garcia, A. Sebio
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1583O Clinical benefit of cancer drugs approved in Switzerland during the last decade
Adam, R., Tibau, A., Molto Valiente, C., Seruga, B., Ocaña, A., Amir, E., Templeton, A.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1585MO Factors associated with change in overall survival and quality of life between time of approval and post-marketing among anti-cancer therapies
Bujosa Rodríguez, A., Molto Valiente, C., Tapia, J.C., Gich, I., Barnadas, A., Amir, E., Tibau, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
8026 The predictive and prognostic value of serum CA125 kinetics and CA125 nadir during paclitaxel/platinum based chemotherapy (QT) in patients with advanced ovarian carcinoma (OC)
Tibau, A, Ojeda, M.B, Nadal, R.M, Gallardo, A, Altozano, J. Pérez, Sala, N, Mazarico, J.M, Boguña, I, Artigas, V, Barnadas, A
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article